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Bartonella bacilliformis is the etiologic agent ofOroya fever in humans. Flagellum-mediated motility has been
postulated as a major virulence factor for invasion of host cells. To address this hypothesis, we purified and
characterized flagella from strain KC584 and then assessed their role in human erythrocyte association and
invasion. Electron microscopy of the flagellar preparation showed a high concentration of filaments with a
mean wavelength of 800 nm. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immunoblot analysis,
and KBr density gradient centrifugation indicated that the flagellar filament is composed of a polypeptide of 42
kDa. The flageHlin is partially (ca. 50%) resistant to treatment with trypsin. The first 17 amino acid residues
of the N terminus of the mature flagellin protein are GAAILTNDNAMDALQDL and show approximately 46%
sequence identity to the residues of the N termini of two Caulobacter crescentus flagellin proteins. A
monospecific polyclonal antibody to the flagellin protein was generated, and its specificity was verified by both
immunoblot and immunogold analyses. Human erythrocyte invasion assays performed with bartonellae
exposed to the antiflagellin antiserum showed a significant decrease in bacterial association with and invasion
of human erythrocytes in comparison with that in bartonellae exposed to preimmune rabbit serum or
phosphate-buffered saline (PBS) controls. These results suggest that flagella are an important component in the
invasiveness of B. bacitifortnis.
Bartonella bacilliformis is an intracellular bacterial para-
site of humans. The agent is transmitted by the bite of
nocturnal sand flies of the Phlebotomus genus and is en-
demic to the Andes regions of Peru, Ecuador, and Columbia
(15, 23). Thus far, only humans have been identified as
reservoirs for the bacterium (8). The disease caused by
this organism is known as Carrion's disease and mani-
fests itself in two distinct phases. In the primary (hematic)
phase of the disease, nearly all of the circulating erythro-
cytes are invaded, culminating in a severe hemolytic anemia
which reduces the density of erythrocytes by nearly 80%
(8). In the preantibiotic era, this phase of the disease, known
as Oroya fever, was fatal in approximately 40% of cases
(15). In the secondary (tissue) phase of the disease, organ-
isms which have invaded capillary endothelial cells in-
duce cellular proliferation (7), resulting in hemangioma-like
nodules, termed verruga peruana, on the extremities and
face. This phase of the disease is rarely fatal and presents
within 1 to 2 months of the primary infection (7, 23).
Recovery from bartonellosis is complete, but persistent
carrier states sometimes occur (6). B. bacilliformis is placed
in the Rickettsiales family on the basis of its 16S rRNA
sequence homology (4, 5), cell size, and route of transmis-
sion (4). However, within this family, B. bacilliformis is
uniquely motile, possessing 1 to 10 polar flagella 3 to 10 ,um
in length (15).
The mechanism by which B. bacillifornis gains entry into
erythrocytes has not been studied extensively. Previous
studies showed that there is a bacterial energy require-
ment for host cell invasion to occur, indicating that the
* Corresponding author.
organism plays an active role in the process (26). It has
also been shown that treatment of host cells with cytocha-
lasin D partly reduces the efficiency of invasion of human
dermal fibroblasts, laryngeal epithelium, and umbilical vein
endothelium, suggesting that the host cell may play a micro-
filament-dependent role in the uptake of bartonellae (12). B.
bacilliformis also produces an extracellular proteinaceous
factor that deforms the erythrocyte membrane, causing deep
invaginations (17). This deformation factor may be associ-
ated with the ability of the bacterium to invade erythrocytes.
However, even with deformation of the erythrocyte mem-
brane, bartonellae cannot invade unless they are motile (17).
It is likely that flagellum-based motility and the deformation
factor act in concert to facilitate entry into erythrocytes.
To gain a better understanding of the factors necessary
for host cell invasion, we isolated and characterized the
flagellin of B. bacilliformis and determined that antiflagel-
lin antibodies significantly decrease the ability of the organ-
ism to associate with and gain entry into human erythro-
cytes.
MATERUILS AND METHODS
Bacterial strains and growth conditions. B. bacilliformis
KC583 and KC584 were obtained from the American Type
Culture Collection, Rockville, Md. Bacteria were routinely
grown on heart infusion agar (Difco Laboratories, Detroit,
Mich.) supplemented with 5% defibrinated sheep erythro-
cytes and 5% sheep serum (Colorado Serum Co., Denver) at
30°C in a water-saturated atmosphere. Growth was usually
observed by 3 days, and cultures were used at 5 days
postinoculation for experiments.
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Purification of flagella. The contents of approximately 50
petri plates of B. bacilliformis KC584 were harvested into 25
ml of phosphate-buffered saline (PBS) (pH 7.4), placed in a
50-ml centrifuge tube, and vortexed vigorously for 2 min.
This preparation was centrifuged at 6,000 x g for 25 min at
4°C to remove cellular debris. The supernatant was then
centrifuged at 100,000 x g in an SW28 rotor (Beckman
Instruments, Fullerton, Calif.) for 3 h at 4°C. The resulting
pellet was resuspended in 0.5 ml of distilled water. This
crude flagellar preparation (CFP) was observed by transmis-
sion electron microscopy and analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
(16). For further purification, the CFP was fractionated with
KBr density gradients (0.5 g of KBr per ml of H20) as
described by Kalmokoff et al. (14). Approximately 125 ,ug
of protein from the CFP was layered onto a KBr gradient
and centrifuged for 24 h at 260,000 x g in a Beckman SW60
rotor at 4°C. Two visible bands were subsequently removed
from the gradient by aspiration and analyzed by transmis-
sion electron microscopy and SDS-PAGE with silver stain-
ing.
Trypsin treatment. The trypsin sensitivity of the flagellin
was determined by incubating 10 ,ul (approximately 30 ,ug of
total protein) of intact B. bacillifornis KC584 cells sus-
pended in Hanks buffered saline solution (HBSS) with
high-pressure liquid chromatography-purified trypsin (Sigma
Chemical Co., St. Louis, Mo.) at a final concentration of 2
mg/ml for 2 h at 30°C. Molecular mass standards (0.5 ,ug of
total protein) were similarly digested with trypsin as a
positive control, and bartonellae incubated in HBSS without
trypsin served as a negative control. The reaction was
stopped by adding 20 ,ul of Laemmli sample buffer (16), and
the entire reaction mixture was run in SDS-PAGE and
stained with Coomassie brilliant blue. SDS-polyacrylamide
gels of the trypsin digest were also analyzed by use of
immunoblots developed with rabbit antiflagellin antiserum
to confirm the identity of the trypsin-resistant 42-kDa
protein band on SDS-polyacrylamide gels. Densitometry
scans of Coomassie brilliant blue-stained gels were per-
formed with an E-C 910 densitometer (E-C Apparatus Corp.,
St. Petersburg, Fla.) interfaced with a Perkin-Elmer LCI-100
laboratory computing integrator (Perkin-Elmer, Norwalk,
Conn.).
SDS-PAGE and immunoblotting. SDS-PAGE was carried
out by the method of Laemmli (16) with 10 or 12.5% (wt/vol)
polyacrylamide gels. To visualize protein bands, the gels
were stained with silver (27) or Coomassie brilliant blue (22).
Immunoblotting was carried out essentially as described by
Towbin et al. (25). Unfixed SDS-polyacrylamide gels were
blotted to nitrocellulose (0.45-,m-pore size; Schleicher &
Schuell, Inc., Keene, N.H.) in 20 mM sodium phosphate
buffer (pH 8.0). The blots were electrophoresed overnight at
a constant voltage of 15 V with constant cooling. The
nitrocellulose was incubated for 1 h at 22°C in blocking
solution (PBS [pH 7.4], 0.3% [vol/vol] Tween 20, 2% [wt/vol]
nonfat milk) and then with rabbit antiflagellin or rabbit
anti-B. bacillifornis antiserum at a 1:2,000 dilution in PBS
(pH 7.4)-0.3% Tween 20 for 2 h. The blots were subse-
quently washed five times in PBS for 10 min and then
incubated for 1 h with a 1:2,000 dilution of horseradish
peroxidase-conjugated goat anti-rabbit immunoglobulin G
(Sigma) in PBS. The blots were washed five times in PBS for
10 min and then developed in a solution containing 50 ml of
PBS, 10 ml of 4-chloro-1-naphthol in methanol (3 mg/ml),
and 75 t.I of 30% H202. Development was stopped by rinsing
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FIG. 1. Comparison of the CFP of B. bacillifonnis with bacterial
cell lysates on Coomassie brilliant blue-stained SDS-polyacrylamide
gels (10% acrylamide). Lanes: 1, molecular mass standards in
kilodaltons; 2, B. bacillifornis KC583 whole-cell lysate; 3, B.
bacillifornis KC584 whole-cell lysate; 4, CFP isolated from strain
KC584. The arrowhead indicates the position of the 42-kDa band
identified as fiagellin.
the blots thoroughly in distilled water. The blots were stored
in the dark to prevent fading of the bands.
N-terminal sequencing. A preparative SDS-polyacrylamide
gel was run with a Tricine running buffer system (0.1 M Tris
base, 0.1 M Tricine, 0.1% SDS). The gel was blotted to an
Immobilon polyvinylidene difluoride membrane (Millipore
Corp., Bedford, Mass.) as described above for the immuno-
blot procedure. The membrane was then fixed for 30 min in
a fixer containing 25% isopropanol and 7% acetic acid,
stained for 30 min in this fixer containing 0.25% Coomassie
brilliant blue, and destained in this fixer until the bands were
visible. The membrane was subsequently rinsed several
times in distilled water, and the 42-kDa flagellin band was
removed and sequenced on a model 473A automated protein
sequencer (Applied Biosystems, Foster City, Calif.).
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FIG. 2. Immunoblot analysis of a B. bacilliformis cell lysate and
the CFP with anti-B. bacilliformis antiserum. (A) Coomassie bril-
liant blue-stained SDS-polyacrylamide gel (12.5% acrylamide). (B)
Corresponding immunoblot. Lanes: 1, molecular mass standards in
kilodaltons; 2, B. bacilliformis KC584 whole-cell lysate; 3, CFP.
The arrows indicate the 42-kDa flagellin band.
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FIG. 3. (A) Coomassie brilliant blue-stained SDS-polyacryl-
amide gel (12.5% acrylamide) containing trypsin-treated flagella.
Lanes: 1, molecular mass standards in kilodaltons (0.5 ,ug); 2, the
same molecular mass standards digested for 2 h at 30°C with trypsin
at 2 mg/ml; 3, whole-cell lysate of intact KC584 cells incubated as in
lane 4 but without trypsin; 4, trypsin digest (2 h at 30°C with 2 mg
of trypsin per ml) of intact KC584 cells showing the residual flagel-
lin band. (B) Corresponding immunoblot developed with rabbit
antiflagellin antiserum. The arrows indicate the 42-kDa flagellin
band.
Transmission electron microscopy. Samples (10 ,ul) were
placed on Formvar-coated grids and allowed to incubate for
15 min at 22°C. The grids were then rinsed twice for 2 min
each time with distilled water and negatively stained with
0.33% (wt/vol) aqueous uranyl acetate for 15 s. The grids
were then air dried and observed at 75 kV with a model 7100
transmission electron microscope (Hitachi, Mountain View,
Calif.).
Antibody production. To prepare monospecific polyclonal
antiserum to the flagellin, the 42-kDa flagellar filament pro-
tein was isolated from the CFP by preparative SDS-PAGE.
The CFP (100 ,ug) was run on preparative gels and stained
with Coomassie brilliant blue, and the 42-kDa flagellin pro-
tein band was removed with a razor blade, minced, and
emulsified with 0.5 ml of PBS-0.5 ml of Freund's incomplete
adjuvant (Sigma). The sample was subcutaneously injected
into an adult male New Zealand White rabbit at three depots
above the shoulder. After 3 weeks, the rabbit was given a
booster of an equal quantity of the flagellin sample in a
similar manner. Antiserum was collected 2 and 3 weeks
following the booster and stored in 0.5-ml aliquots at -20°C
until used.
To prepare anti-B. bacilliformis antiserum, bacteria were
suspended in sterile PBS containing formalin (0.1% [vol/vol])
to a final density of approximately 109 cells per ml and
incubated for 4 h at 22°C. Bacterial death was ascertained by
plate counts. An adult male New Zealand White rabbit was
injected intravenously with approximately 3 x 108 cells of
the formalin-killed bacteria. Six injections were adminis-
tered at 48-h intervals. Antiserum was collected 2 weeks
following the sixth injection.
Immunogold assays. Immunogold assays were performed
by a modification of the procedure of Timmerman et al. (24).
In brief, approximately 3 mg (wet weight) of B. bacillifornis
was resuspended in 0.5 ml of heart infusion broth containing
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FIG. 4. KBr density gradient fractionation of the CFP. (A)
Silver-stained SDS-polyacrylamide gel (12.5% acrylamide) contain-
ing fractions from the KBr gradient. Lanes: 1, molecular mass
standards in kilodaltons; 2, CFP; 3, band 1 (low-density band) from
the KBr gradient; 4, band 2 (high-density band) from the KBr
gradient. The arrow indicates the 42-kDa flagellin band. (B) Trans-
mission electron micrograph of KBr band 2 showing a high density
of flagella.
0.5 ml of 0.5% glutaraldehyde-2% paraformaldehyde in PBS
(pH 7.4) and allowed to incubate for 1 h at 22°C. The cells
were pelleted at 1,500 x g in a microcentrifuge for 10 min,
decanted, resuspended in 0.5 ml of 50 mM glycine in PBS,
and incubated for 1 h. The cells were pelleted, resuspended
in 0.45 ml of PBG (0.5% bovine serum albumin [BSA]-1%
gelatin in PBS), and incubated for 1 h. The cells were
pelleted, resuspended in 0.45 ml of PBG with 20 ,ul of rabbit
antiflagellin serum, and incubated for 1 h. The cells were
rinsed four times in 0.5 ml of PBG for 10 min each time and
resuspended in 0.45 ml of protein A-gold buffer (0.15 M NaCl
[pH 7.0], 0.5% BSA, 0.5% Tween 20). To this mixture, 20 ,ul
of protein A-gold (Sigma) was added and incubated for 1 h.
The cells were washed four times for 10 min each time in 0.5
ml of PBG and then four times for 10 min each time in
distilled water. Finally, the bacteria were negatively stained
and observed by transmission electron microscopy.
Invasion assays. One petri plate of B. bacilliformis was
overlaid with 5 ml of liquid bartonella growth medium (3) for
5 min at 22°C. A 1-ml aliquot of the growth medium was
gently removed, and the bacteria were enumerated on a
Petroff-Hausser cell counter. Approximately 105 bacteria
were placed into microcentrifuge tubes, adjusted to a final
volume of 0.1 ml, and treated with 0.1 ml of rabbit antiflagel-
lin serum, PBS (pH 7.4), or preimmune rabbit serum. After
1 h, human erythrocytes (American Red Cross) which had
been washed twice in PBS-GI (PBS supplemented with 10
mM glucose and 5 mM inosine) were added to the tubes to
yield a bacterium/erythrocyte multiplicity-of-infection ratio
of 500:1. The tubes were then centrifuged at 1,500 x g for 5
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FIG. 4-Continued.
min to increase the association of the bacteria with the
erythrocytes and incubated for 10 h at 30°C to allow for
invasion.
For enumeration of bacteria associated with erythrocytes
via Giemsa staining, 0.1 ml of each invasion reaction mixture
was centrifuged at 1,500 x g on a 70% Percoll gradient as
described by Benson et al. (3) to separate free bacteria from
erythrocytes after the 10-h incubation. Gradients were made
by adding 0.3 ml of 0.51 M NaCl to 0.7 ml of Percoll (Sigma)
and centrifuging the mixtures at 10,000 x g for 10 min in a
microcentrifuge. The gradients were briefly stored at 4°C
until needed. The erythrocyte band was removed from the
gradients with a syringe, and the residual Percoll was re-
moved from the erythrocytes by three brief washes in
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FIG. 5. Immunoblot analysis showing the specificity of the anti-
flagellin antiserum for a B. bacillifornis cell lysate and the CFP. (A)
Coomassie brilliant blue-stained SDS-polyacrylamide gel (12.5%
acrylamide). (B) Corresponding immunoblot developed with the
antiflagellin antiserum. Lanes: 1, molecular mass standards in
kilodaltons; 2, CFP; 3, B. bacillifornis KC584 whole-cell lysate.
The arrows indicate the 42-kDa flagellin band.
PBS-GI, with centrifugations between the washes. Erythro-
cyte-associated bacteria were observed and counted by light
microscopy following Giemsa staining.
Enumeration of intracellular bacteria was achieved by a
modification of an invasion assay described by Jones et al.
(13). In brief, 10-h invasion reaction mixtures (multiplicity of
infection ratio, 5:1) were pelleted at 1,500 x g, resuspended
in PBS-GI containing gentamicin sulfate (250 ,ug/ml [Sigma]),
and incubated for 3 h at 30°C. This antibiotic kills only
extracellular bacteria, since it cannot enter erythrocytes.
The cells were then pelleted at 1,500 x g in a microcentrifuge
and briefly washed three times in PBS-GI, with centrifuga-
tions between the washes. The pelleted cells were resus-
pended in 0.2 ml of sterile PBS, twofold serially diluted,
lysed by adding 3 volumes of sterile distilled water, and
plated. Colonies representing intracellular (invasive) bacte-
ria were observed after 8 days of incubation.
Statistical analysis. Numerical values are expressed as
means standard errors of the means. Statistical signifi-
cance of the data was ascertained by use of Student's t test.
A P value of <0.05 was considered significant.
RESULTS
Isolation and identification of the flagellin protein. When
the CFP of B. bacilliformis was visualized on Coomassie
brilliant blue-stained SDS-polyacrylamide gels two promi-
nent bands of 33 and 42 kDa plus minor bands of 34, 45, and
65 kDa were fractionated from the total cell lysate (Fig. 1).
Electron microscopic examination of the CFP revealed that
it contained a high density of flagellar filaments with a mean
wavelength of 800 nm, suggesting that one of the major
protein bands was the flagellar filament protein.
Since flagella are known to be highly antigenic polypep-
tides, immunoblot analyses with rabbit anti-B. bacilliformis
antiserum were performed to identify highly reactive pro-
teins in the CFP. Figure 2B shows the proteins recognized
by the anti-B. bacilliformis antiserum in both the bartonella
whole-cell lysate (lane 2) and the CFP (lane 3). Along with a
variety of proteins, the 42-kDa protein was strongly recog-
nized in both the B. bacilliformis whole-cell lysate and the
CFP.
Invasion of erythrocytes by B. bacilliformis was previ-
ously shown to be resistant to trypsin treatment (17). Since
motility appears to play a central role in invasion, we
hypothesized that the trypsin resistance of the flagellin
protein might account for this observation. Indeed, digestion
of intact bartonellae with trypsin showed that a 42-kDa
protein of the bacterium was partially resistant (ca. 50%, as
determined by densitometry) to degradation by trypsin,
whereas the majority of the proteins in the gel were digested
(Fig. 3A). Immunoblot analysis of the trypsin digest with
rabbit antiflagellin antiserum subsequently confirmed the
identity of the 42-kDa protein band as flagellin (Fig. 3B).
With these data, we tentatively identified the 42-kDa
protein band in the CFP as the flagellin protein. To confirm
this identification, additional purification steps were taken.
Further purification of flagella was achieved by fractionation
of the CFP by KBr buoyant density gradient centrifugation.
KBr density gradient centrifugation of the CFP yielded two
distinct bands of low and high density, designated bands 1
and 2, respectively. The presence of the 42-kDa protein on
silver-stained SDS-polyacrylamide gels correlated with the
appearance of flagella in transmission electron micrographs.
Only gradient band 2 contained the 42-kDa protein, as seen
on silver-stained SDS-polyacrylamide gels (Fig. 4A, lane 4),
and flagella, when observed by transmission electron mi-
croscopy (Fig. 4B). Gradient band 1 did not show a 42-kDa
protein in SDS-PAGE (Fig. 4A, lane 3) and contained no
flagella, as determined by transmission electron microscopy
(data not shown).
Immunoblot analysis. The specificity of the antiflagellin
polyclonal antiserum generated against the 42-kDa protein
band was initially assessed by an immunoblot analysis. The
42-kDa protein was specifically recognized by the antiflagel-
lin antiserum in both the CFP and the whole-cell lysate of B.
bacilliformis KC584 (Fig. 5). This serum also specifically
recognized a 42-kDa protein in strain KC583 of B. bacilli-
fonnis but did not cross-react with Escherichia coli or
Salmonella typhimurium flagellin or other cellular proteins in
immunoblot analyses (data not shown).
Immunogold analysis. Immunogold analysis was used to
verify that the 42-kDa protein used to generate the antiflagel-
lin antiserum was indeed the flagellar filament protein as well
as to demonstrate the specificity of the antiflagellin poly-
clonal antiserum. This analysis showed that the antiserum
recognized the flagella of B. bacilliformis and did so with a
high specificity. Figure 6A shows that the flagella are
strongly recognized by the antiflagellin polyclonal anti-
serum, and Fig. 6B demonstrates its specificity for this
structure, as indicated by the absence of gold particles on the
surface of the bacterial cell. This analysis, together with the
immunoblot analysis (Fig. 5), showed that the 42-kDa pro-
tein used to generate the antiserum was indeed the flagellin
protein of B. bacilliformis KC584 and that the antiflagellin
polyclonal antiserum was monospecific.
N-terminal sequence of the flagellin. The N-terminal se-
quence of the 42-kDa flagellar filament protein was deter-
mined in triplicate and found to be GAAILTNDNAM
DALQDL. This sequence showed 52.9 and 41.2% sequence
identity to the N termini of the 25-kDa flagellin (18) and
28.5-kDa flagellin (9) from Caulobacter crescentus, respec-
tively, when analyzed by PC Gene 8.0 release 24 (Intellige-
netics, Mountain View, Calif.). Figure 7 shows the alignment
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of the first 17 amino acids from the B. bacilliformis flagellin
and the two flagellins from C. crescentus.
Invasiveness of B. bacilliformis in the presence of antiflagel-
lin antibodies. To assess whether antiflagellin antibodies
could inhibit the invasiveness of B. bacilliformis, invasion
assays were performed in the presence or absence of anti-
flagellin antiserum. Invasiveness was scored by two meth-
ods.
The first protocol was to observe invaded human erythro-
cytes by Giemsa staining and enumerate the invaded eryth-
rocytes. Since it was impossible to determine whether the B.
bacillifonnis cells were intra- or extracellular by this assay,
infected erythrocytes were referred to as having intimately
associated bacteria. Two separate invasion assays were run
with antiflagellin antiserum, preimmune rabbit serum, and a
PBS control. Two sets of 1,000 erythrocytes were scored for
associated bacteria after Giemsa staining. The staining re-
vealed considerable agglutination of bacteria in the anti-
flagellin antiserum-treated invasion assays that was absent in
PBS and preimmune rabbit serum control assays. The anti-
flagellin antiserum significantly reduced the number of eryth-
rocytes with associated bacteria by approximately 52%
(P < 0.003) and 41% (P < 0.005) in comparison with PBS
and preimmune rabbit serum control assays, respectively
(Fig. 8A). Differences between the PBS and preimmune
serum control assays were not statistically significant (Fig.
8A).
The second method used to enumerate invaded human
erythrocytes was done with the antibiotic gentamicin. In this
assay, a gentamicin solution was added after the 10-h inva-
sion incubation to kill any extracellular bacteria. The reduc-
tions in bacterial invasion conferred by the antiflagellin
antiserum were approximately 99.8 and 99.7% in comparison
with PBS and preimmune rabbit serum control assays,
respectively (Fig. 8B). Both of these reductions were highly
significant (P < 0.0001 and P < 0.001, respectively). Preim-
mune rabbit serum could also significantly reduce invasion,
by approximately 31.5% relative to that in PBS controls (P <
0.03) (Fig. 8B).
DISCUSSION
B. bacilliformis, a member of the Rickettsiales family, is
an intracellular parasite of human erythrocytes which causes
one of the most severe hemolytic anemias known (8).
Although the threat of B. bacilliformis as a serious health
problem has been reduced with the introduction of antibiot-
ics and vector control within regions of endemicity, docu-
mented epidemics have occurred as recently as 1987, with
serious consequences (10). In addition to the ultimate goal of
preventing bartonellosis, studies of this organism will pro-
vide insight into the biology of intracellular parasites, more
specifically hemotrophic organisms.
This study provides the first molecular characterization of
flagella from B. bacilliformis and the potential role that they
play in the invasion process. We have identified a 42-kDa
protein in B. bacillifonnis KC584 as the flagellin protein
through the use of fractionation, transmission electron mi-
croscopy, and a monospecific antiserum generated against
the protein. The antiflagellin antiserum cross-reacts with a
42-kDa protein from B. bacilliformis KC583 but shows no
cross-reactivity with either E. coli or S. typhimurium pro-
teins in immunoblot analyses. Immunogold assays showed
that the antiflagellin antiserum is specific for the flagella ofB.
bacilliformis and no other cell surface structures. Although
the evidence presented here shows that the flagella of B.
bacilliformis KC584 are composed of a single 42-kDa flagel-
lin subunit, our results do not preclude the possibility that a
second flagellin protein of 42 kDa and with a conserved N
terminus also exists.
A number of previous studies on B. bacillifonnis have
implicated the importance of motility, i.e., functional fla-
gella, in invasiveness. Benson et al. (3) observed that B.
bacilliformis was able to deform the erythrocyte membrane
in an irreversible fashion and attributed this ability to the
motility of the bacterium. They postulated that the motile
bacteria could act in a manner similar to that of a drill and,
in conjunction with other factors, permanently alter the
erythrocyte membrane. They also found that nonmotile
mutants (or old cultures with reduced motility) bound
poorly, if at all, to erythrocytes. It was hypothesized either
that the loss of motility reduced the number of interactions
between the bacterium and host cells and abrogated the
"drill" effect of the bacterium or that the nonmotile B.
bacillifornis cells lacked a surface receptor necessary for
attachment (3).
A more recent study by Memaugh and Ihler (17) on the
invasive attributes of B. bacilliformis identified a protein-
aceous factor released by the bacterium during growth in
vitro and with the ability to deform the erythrocyte mem-
brane independently of the pathogen. This factor, termed the
deformation factor, irreversibly causes deformations in the
erythrocyte membrane much like those originally attributed
to flagella (3). While motility is apparently not responsible
for the invaginations and trenches on the erythrocyte surface
(17), it is still essential for invasion by B. bacilliformis to
occur (17). Therefore, the deformation factor and motility
probably act in concert to promote membrane deformation
and entry, respectively, into erythrocytes. Memaugh and
Ihler (17) also found that the invasion process was insensi-
tive to trypsin at a concentration of 1 mg/ml. The partial
resistance (approximately 50%) of flagellin to trypsin at
twice that concentration in this report (Fig. 3) is in keeping
with their observations.
Hill et al. (12) found that invasion by B. bacillifonnis of
human dermal fibroblasts, laryngeal epithelial cells, and
umbilical vein endothelial cells was diminished by approxi-
mately 50% when the bacteria were treated with B. bacilli-
formis whole-cell antiserum. This reduction in invasion
corresponds very well with the 41 to 99.8% reduction that we
report here with antiflagellin antiserum (Fig. 8). Given this
similarity, it is possible that the reduction in invasion seen by
Hill et al. (12) was at least in part due to the presence of
antiflagellin antibodies in their antiserum. Cytochalasin D
can also reduce invasion by B. bacillifonnis of endothelial,
epithelial, and fibroblast cells, indicating microfilament-de-
pendent activity on the part of the host cell (12). However,
prevention of invasion in the presence of cytochalasin D is
not complete, suggesting that B. bacilliformis plays an active
role in the invasion process. Since erythrocytes are nonen-
docytic, entry would necessarily be pathogen dependent and
passive with respect to the host cell. In any case, it seems
that invasion by B. bacilliformis of host cells is a complex
interaction that relies upon several factors, including the
recently characterized deformation factor, host cell micro-
filaments, and functional bacterial flagella.
In addition to supplying the mechanical force for invasion,
the flagellin of B. bacilliformis has been speculated to be
involved in attachment to erythrocytes. Walker and Winkler
(26) noted that a significant number of bacteria were attached
to erythrocytes via fiber-like projections from one pole of the
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FIG. 6. Transmission electron micrographs of the immunogold assays. (A) KBr-purified flagella from B. bacillifonnis KC584 labelled with
the antiflagellin antiserum and protein A-gold. (B) Immunogold analysis of an intact B. bacilliformis KC584 cell showing the specificity of the
antiflagellin antiserum for flagella on the bacterial cell surface.
organism when observed under electron microscopy. This
observation is of obvious interest, since B. bacillifonnis has
multiple polar flagella. The attachment of bacteria to host
cells via flagella is known to occur in Vibrio cholerae, for
which attachment to host cells is apparently dependent on
the presence of flagella rather than their functional state (20).
Our data do not preclude this possible role for flagella in B.
bacilliformis. The reduction in invasiveness that we report
here in the presence of antiflagellin antiserum (Fig. 8) could
be due to a masking of attachment sites on the flagella in
addition to a reduction in motility by agglutination of the
bacteria.
It is clear that invasion (Fig. 8B) is inhibited to a much
greater extent than erythrocyte association (Fig. 8A) when
bartonellae are treated with antiflagellin antiserum. Assum-
ing that flagella are involved in host cell attachment, these
observations suggest that antibody blocking of flagellar
receptor sites is only partial or, alternatively, that other
adhesins are involved. Our data also suggest that preimmune
rabbit serum reduces the invasiveness of B. bacilliformis by
approximately 31.5% in comparison with PBS controls (Fig.
8B). While this is a significant reduction in invasiveness (P <
0.03), it is obvious that antiflagellin antiserum is significantly
more effective at reducing invasiveness and results in an
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FIG. 7. Comparison of the N-terminal amino acid sequences of
B. bacilliformis KC584 flagellin and two C. crescentus flagellins.
The first 17 amino acid residues from the B. bacilliformis sequence
(BBFLAG) are compared with the first 17 amino acids of published
sequences for the 25-kDa flagellin (FLA 1) (18) and the 28.5-kDa
flagellin (FLA 2) (9) from C. crescentus.
approximately 68.3% greater reduction in CFU than preim-
mune serum, relative to PBS controls (Fig. 8B).
The reduction in erythrocyte association and invasion
obtained by treatment of B. bacillifornis with antiflagellin
antiserum is not surprising. In studies with Proteus mirabi-
lis, investigators found that mutants which lack flagella could
not invade host cells (1). Even P. mirabilis mutants deficient
in swarming ability and with only partial motility had signif-
icantly reduced invasiveness (1). Flagellin-specific antibod-
ies are produced in P. mirabilis-infected mice and can
prevent the spread of the bacterium as well as decrease the
ability of the bacterium to initiate infection (2, 11). Flagellin
preparations used as vaccines also confer protection against
a lethal challenge with P. mirabilis in mice (2). Inhibition of
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masking an attachment site on the flagella, or both is
currently under investigation.
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